Measure 1.2
Project
Clinical study of the FlexiOss bone substitute biocomposite referred to as “artificial bone” as part of the Lubelskie Voivodeship Regional Operational Programme 2014-2020, Measure 1.2 Targeted research.
Project objective
The aim of the project is to conduct clinical trials of an invention of a bone substitute biomaterial referred to as “artificial bone”, which is innovative on an international scale, and to start research into a new material functionally complementary to the biocomposite.
Planned results
Conducting clinical trials of the FlexiOss bone substitute biocomposite will allow the product to be fully introduced to the commercial market, which will promote the widespread use of “artificial bone” in medicine.
Achieving high surgical convenience and adaptability of the composite to the dimensions of the bone defect to be filled and minimising the risk of viral contamination through the use of a bacterial polymer, thereby improving patients’ quality of life.